Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 67.80
-0.60 (-0.88%)
Oct 22, 2026, 11:21 AM CEST
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 842.11 million as of October 21, 2026. It is the 9,929th most valuable company in the world and the 121st biggest in Switzerland. Its market cap has increased by 40.87% in one year.
Market Cap
842.11M
Enterprise Value
752.50M
Revenue
247.42M
Global Rank
Country Rank
#121 Switzerland
PE Ratio
16.91
ChartMarket Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 842.11M, an increase of 57.91%. That is a compound annual growth rate of 2.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 842.11M | 25.29% |
| Dec 30, 2025 | 672.13M | 34.10% |
| Dec 30, 2024 | 501.21M | 18.52% |
| Dec 29, 2023 | 422.90M | -22.52% |
| Dec 30, 2022 | 545.84M | 12.62% |
| Dec 30, 2021 | 484.67M | -15.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.44B |
| Idorsia | 1.14B |
| Santhera Pharmaceuticals Holding AG | 224.94M |
| Newron Pharmaceuticals | 180.53M |
| BioVersys AG | 143.11M |
| Molecular Partners AG | 116.83M |
| Xlife Sciences AG | 52.25M |
| MindMaze Therapeutics Holding | 25.33M |